1. Binder MJ, McCoombe S, Williams ED, McCulloch DR, Ward AC. The extracellular matrix in cancer progression: role of hyalectan proteoglycans and ADAMTS enzymes. Cancer Lett 2017;385:55-64.

2. Tsuda T. Extracellular interactions between fibulins and transforming growth factor (TGF)-beta in physiological and pathological conditions. Int J Mol Sci 2018;19:E2787.

3. Spaw M, Anant S, Thomas SM. Stromal contributions to the carcinogenic process. Mol Carcinog 2017;56:1199-213.

4. Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol 2015;16:113.

5. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, et al. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997;272:556-62.

6. Shindo T, Kurihara H, Kuno K, Yokoyama H, Wada T, et al. ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest 2000;105:1345-52.

7. Iruela-Arispe ML, Carpizo D, Luque A. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci 2003;995:183-90.

8. Brown HM, Dunning KR, Robker RL, Boerboom D, Pritchard M, et al. ADAMTS1 cleavage of versican mediates essential structural remodeling of the ovarian follicle and cumulus-oocyte matrix during ovulation in mice. Biol Reprod 2010;83:549-57.

9. Tan Ide A, Ricciardelli C, Russell DL. The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways. Int J Cancer 2013;133:2263-76.

10. Ricciardelli C, Frewin KM, tan Ide A, Williams ED, Opeskin K, et al. The ADAMTS1 protease gene is required for mammary tumor growth and metastasis. Am J Pathol 2011;179:3075-85.

11. Liu YJ, Xu Y, Yu Q. Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. Oncogene 2006;25:2452-67.

12. Obika M, Ogawa H, Takahashi K, Li J, Hatipoglu OF, et al. Tumor growth inhibitory effect of ADAMTS1 is accompanied by the inhibition of tumor angiogenesis. Cancer Sci 2012;103:1889-97.

13. Hirano T, Hirose K, Sakurai K, Makishima M, Sasaki K, et al. Inhibition of tumor growth by antibody to ADAMTS1 in mouse xenografts of breast cancer. Anticancer Res 2011;31:3839-42.

14. Freitas VM, do Amaral JB, Silva TA, Santos ES, Mangone FR, et al. Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion. Mol Cancer 2013;12:2.

15. Tyan SW, Hsu CH, Peng KL, Chen CC, Kuo WH, et al. Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change. PLoS One 2012;7:e35128.

16. Ham SA, Yoo T, Lee WJ, Hwang JS, Hur J, et al. ADAMTS1-mediated targeting of TSP-1 by PPARdelta suppresses migration and invasion of breast cancer cells. Oncotarget 2017;8:94091-103.

17. Li M, Liu L, Zang W, Wang Y, Du Y, et al. miR365 overexpression promotes cell proliferation and invasion by targeting ADAMTS-1 in breast cancer. Int J Oncol 2015;47:296-302.

18. Cal S, Lopez-Otin C. ADAMTS proteases and cancer. Matrix Biol 2015;44-46:77-85.

19. Lee NV, Rodriguez-Manzaneque JC, Thai SN, Twal WO, Luque A, et al. Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. J Biol Chem 2005;280:34796-804.

20. Argraves WS, Dickerson K, Burgess WH, Ruoslahti E. Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain. Cell 1989;58:623-9.

21. de Vega S, Iwamoto T, Yamada Y. Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 2009;66:1890-902.

22. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci 2002;115:2817-28.

23. Obaya AJ, Rua S, Moncada-Pazos A, Cal S. The dual role of fibulins in tumorigenesis. Cancer Lett 2012;325:132-8.

24. Greene LM, Twal WO, Duffy MJ, McDermott EW, Hill AD, et al. Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br J Cancer 2003;88:871-8.

25. Twal WO, Czirok A, Hegedus B, Knaak C, Chintalapudi MR, et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 2001;114:4587-98.

26. Qing J, Maher VM, Tran H, Argraves WS, Dunstan RW, et al. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 1997;15:2159-68.

27. Timpl R, Sasaki T, Kostka G, Chu ML. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 2003;4:479-89.

28. Moll F, Katsaros D, Lazennec G, Hellio N, Roger P, et al. Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 2002;21:1097-107.

29. Sadlonova A, Bowe DB, Novak Z, Mukherjee S, Duncan VE, et al. Identification of molecular distinctions between normal breast-associated fibroblasts and breast cancer-associated fibroblasts. Cancer Microenviron 2009;2:9-21.

30. Xu Z, Chen H, Liu D, Huo J. Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study. Medicine (Baltimore) 2015;94:e663.

31. Cheng YY, Jin H, Liu X, Siu JM, Wong YP, et al. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. Br J Cancer 2008;99:2083-7.

32. Kanda M, Nomoto S, Okamura Y, Hayashi M, Hishida M, et al. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol Carcinog 2011;50:571-9.

33. Xiao W, Wang J, Li H, Xia D, Yu G, et al. Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence. BMC Cancer 2014;14:677.

34. Fontanil T, Mohamedi Y, Cal S, Obaya AJ. Assessing the influence of a protease in cell migration using the barrier-migration assay. Methods Mol Biol 2018;1731:133-43.

35. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003;17:1253-70.

36. Gyorffy B, Benke Z, Lanczky A, Balazs B, Szallasi Z, et al. RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data. Breast Cancer Res Treat 2012;132:1025-34.

37. Schiemann WP, Blobe GC, Kalume DE, Pandey A, Lodish HF. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem 2002;277:27367-77.

38. Mohamedi Y, Fontanil T, Solares L, Garcia-Suarez O, Garcia-Piqueras J, et al. Fibulin-5 downregulates Ki-67 and inhibits proliferation and invasion of breast cancer cells. Int J Oncol 2016;48:1447-56.

39. Alford AI, Kozloff KM, Hankenson KD. Extracellular matrix networks in bone remodeling. Int J Biochem Cell Biol 2015;65:20-31.

40. Kern CB, Twal WO, Mjaatvedt CH, Fairey SE, Toole BP, et al. Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev Dyn 2006;235:2238-47.

41. Martino-Echarri E, Fernandez-Rodriguez R, Rodriguez-Baena FJ, Barrientos-Duran A, Torres-Collado AX, et al. Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2. Int J Cancer 2013;133:2315-24.

42. Porter S, Scott SD, Sassoon EM, Williams MR, Jones JL, et al. Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res 2004;10:2429-40.

43. Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, et al. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. Am J Pathol 2009;174:1650-62.

44. Esselens C, Malapeira J, Colome N, Casal C, Rodriguez-Manzaneque JC, et al. The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration. J Biol Chem 2010;285:2463-73.

45. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-49.

46. Lu X, Wang Q, Hu G, van Poznak C, Fleisher M, et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev 2009;23:1882-94.

47. Fontanil T, Rua S, Llamazares M, Moncada-Pazos A, Quiros PM, et al. Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells. Oncotarget 2014;5:1253-64.

48. Pupa SM, Argraves WS, Forti S, Casalini P, Berno V, et al. Immunological and pathobiological roles of fibulin-1 in breast cancer. Oncogene 2004;23:2153-60.

49. Feng L, Yao C, Li P, Feng Y, Wang F, et al. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer. Tumour Biol 2016;37:9399-410.

50. Fontanil T, Alvarez-Teijeiro S, Villaronga MA, Mohamedi Y, Solares L, et al. Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells. Oncotarget 2017;8:13716-29.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)


All published articles are preserved here permanently:


All published articles are preserved here permanently: